ANANDA Scientific Announces FDA approval of the IND for the Clinical Trial on the Treatment of Opioid Use Disorder (OUD)
Por um escritor misterioso
Descrição
ANANDA Scientific Inc., (a biotech pharma company) today announced approval by the U.S. Food and Drug Administration (FDA) of the Investigational New
A Decade of FDA-Approved Drugs (2010–2019): Trends and Future Directions
ANANDA Scientific
ANANDA Scientific Announces First Patient Enrolled in the Clinical Trial on the Treatment of Opioid Use Disorder (OUD)
Ketamine, Esketamine, and A New Generation of Antidepressants
40th Annual Meeting of the Society for Medical Decision Making Montréal, Québec, Canada, October 13–17, 2018, 2019
Frontiers A Systematic Review of Opioid Use Disorder and Related Biomarkers
A Decade of FDA-Approved Drugs (2010–2019): Trends and Future Directions
Blog Articles And Insights
Sohail R. Zaidi posted on LinkedIn
